A competitive PCR-based method using TCRD, TCRG and IGH rearrangements for rapid detection of patients with high levels of minimal residual disease in acute lymphoblastic leukemia

[1]  W. Hop,et al.  Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood , 1998, The Lancet.

[2]  H. Cavé,et al.  Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia , 1998 .

[3]  M. Stul,et al.  Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease , 1998, Leukemia.

[4]  G. Morgan,et al.  Comparison of fluorescent consensus IgH PCR and allele‐specific oligonucleotide probing in the detection of minimal residual disease in childhood ALL , 1997, British journal of haematology.

[5]  S. Kinsey,et al.  Quantitative PCR of the immunoglobulin heavy chain gene using genomic DNA , 1996, British journal of haematology.

[6]  H. Cavé,et al.  Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genes. , 1994, Blood.

[7]  A. Morley,et al.  Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction. , 1991, Blood.

[8]  H. Cavé,et al.  Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group. , 1998, The New England journal of medicine.

[9]  J. M.,et al.  Gene Rearrangement in Band T-Lymphoproliferative Disease Detected by the Polymerase Chain Reaction , 2022 .